Papakostas, G. I., Johe, K., Hand, H., Drouillard, A., Russo, P., Kay, G., . . . Fava, M. (2019). A phase 2, double-blind, placebo-controlled study of NSI-189 phosphate, a neurogenic compound, among outpatients with major depressive disorder. Mol Psychiatry.
シカゴスタイル引用形Papakostas, G. I., et al. "A Phase 2, Double-blind, Placebo-controlled Study of NSI-189 Phosphate, a Neurogenic Compound, Among Outpatients With Major Depressive Disorder." Mol Psychiatry 2019.
MLA引用形式Papakostas, G. I., et al. "A Phase 2, Double-blind, Placebo-controlled Study of NSI-189 Phosphate, a Neurogenic Compound, Among Outpatients With Major Depressive Disorder." Mol Psychiatry 2019.
警告: この引用は必ずしも正確ではありません.